Substance Use Disorder

Under the leadership of its board of trustees, The Massachusetts Health & Hospital Association has created a Substance Use Disorder Prevention and Treatment Task Force to develop provider focused strategies to help address the high incidence of opioid misuse that affects our communities.

Click here for detailed information on MHA’s Substance Use Disorder Prevention and Treatment Task Force (SUDPTTF). It is located on the association’s quality and patient safety website, PatientCareLink.
The fight against opioid use disorder (OUD) is about to get a new tool that will make it easier for physicians in hospitals to review risky controlled substances history of patients.
A new Expedited Psychiatric Inpatient Admissions Policy, or EPIA 2.0, builds on the original EPIA that was released in February 2018.
As the nation honors the men and women who have served in the armed forces, it’s appropriate to recognize the special health challenges many veterans face. is up and running, helping individuals locate substance use disorder treatment facilities across the U.S. is up and running, helping individuals locate substance use disorder treatment facilities across the U.S.
Two bills scheduled for action next session would permanently ban all flavored tobacco products, including e-cigarettes, vaping products, and menthol cigarettes.
The Medication Assisted Treatment (MAT) Commission has completed its mandated report to the legislature.
MHA joined Attorney General Maura Healey last week in urging the U.S. Bankruptcy Court in New York to reject Purdue Pharma’s proposed opioid crisis settlement.
MCSTAP wants providers to know that it has the bandwidth to provide quick, free help.
A U.S. District Court judge in Pennsylvania last week ruled that a federal law passed in 1986 to shut down “crack houses” does not apply to those seeking to operate safe injection facilities.
On September 24, Governor Charlie Baker declared a public health emergency due to severe lung disease associated with the use of e-cigarettes and vaping products.
Last Wednesday, the Public Health Council signed off on the final e-prescribing regulations, which go into effect on December 27, 2019.
The Centers for Disease Control and Prevention (CDC) last week announced that it was distributing the first $301 million of a three-year $900 million grant to states to assist them in fighting the opioid crisis.
The federal Substance Abuse and Mental Health Services Administration has released a proposed rule to revise the regulations which serve to protect patient records for the treatment of substance use disorder (SUD) patients.
Boston Medical Center’s Grayken Center for Addiction, through funding from the state Bureau of Substance Addiction Services, is holding a series of trainings across the state for emergency department (ED) nurses on treating opioid use disorder in ED
08.19.2019  | DOI Specialing Update
DOI issued a communication on August 2nd to fully insured health plans providing guidance on coding and billing for additional services (“specialing”) that may be necessary for admissions to inpatient psychiatric units as part of the commonwealth’s E
MHA testified in support of HB1737 / SB1147, An Act Establishing a Behavioral Health Workforce, during Tuesday’s meeting of the Legislature’s Joint Committee on Mental Health, Substance Use & Recovery.
At its July 24 board meeting, the Health Policy Commission (HPC) released its final report (required by Section 130 of Chapter 47 of the Acts of 2017) on the use of third party specialty pharmacies for certain clinician-administered medications.
MassHealth has released several bulletins regarding the coverage and coding of Medication for Addiction Treatment (MAT) in order to increase access to treatment.
Twelve hospitals in Boston and Cambridge have signed a commitment to provide mandatory substance use disorder training to all of their hospital-based physicians and residents in key departments.